# Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma

> **NCT04664413** · — · UNKNOWN · sponsor: **University of Salerno** · enrollment: 300 (estimated)

## Conditions studied

- Papillary Thyroid Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04664413
- **Lead sponsor:** University of Salerno
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-01
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-05-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04664413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04664413, "Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04664413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*